Skip to main content
Jonathan Gerber, MD, Hematology, Worcester, MA, UMass Memorial Medical Center

JonathanMichaelGerberMD

Hematology • Worcester, MA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director of the UMass Cancer Center Chief of Hematology & Oncology Eleanor Eustis Farrington Chair in Cancer Research

Join to view full profile

Dr. Gerber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gerber's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Orthopaedic Surgery, 1999 - 2001
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2018 - 2025
  • NC State Medical License
    NC State Medical License 2013 - 2024
  • MD State Medical License
    MD State Medical License 2008 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Patient Reported Financial Toxicity in Myeloproliferative Neoplasms
    Jonathan M. Gerber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Relationship of minimal residual disease (MRD) in acute lymphocytic leukemia (ALL) and putative leukemia stem cells (LSCs). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • UMass Chan Researcher Explains Convalescent Plasma’s Potential as COVID-19 Treatment
    UMass Chan Researcher Explains Convalescent Plasma’s Potential as COVID-19 TreatmentFebruary 16th, 2022
  • Early Use of Convalescent Plasma Treatment for COVID-19 Helps Avoid Hospitalization
    Early Use of Convalescent Plasma Treatment for COVID-19 Helps Avoid HospitalizationDecember 23rd, 2021
  • ‘We Can Deal with This Virus': In Partnership with Johns Hopkins, UMass Medical School in Worcester Needs Volunteers to Test Early Diagnosis Coronavirus Treatment
    ‘We Can Deal with This Virus': In Partnership with Johns Hopkins, UMass Medical School in Worcester Needs Volunteers to Test Early Diagnosis Coronavirus TreatmentSeptember 21st, 2020
  • Join now to see all

Hospital Affiliations

Dr. Jonathan Gerber, Dr. Jonathan Gerber, MD, Dr. J Gerber, Dr. Jonathan Michael Gerber